ACCESS REALMONEY
Email This Article
Headlines & Perspectives
Discovery Labs Awaits FDA Word on Surfaxin
By
Adam Feuerstein
04/29/08 - 02:02 PM EDT
A regulatory decision on the lung treatment could come May 1, but even with approval the biotech will have to work for every bit of upside.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
